ProfileGDS4459 / ENSG00000163113
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 35% 31% 47% 30% 36% 32% 43% 42% 42% 42% 40% 39% 51% 27% 48% 40% 30% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.9435
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.831
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.2447
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.8530
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.8736
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.7332
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.1343
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.0442
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.0442
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.142
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.9540
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.9139
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.4651
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.6827
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.348
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.140
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.7230